Recent investigations suggest that IFN-γ could be used to convert cancer cells with a cold tumor environment into those with a hot tumor environment and may be combined with immunotherapy for cancer treatment to improve efficacy (Zhang et al., 2019). This evidence concerns the gene IFNG and neoplasm.